Cancer mechanisms

Molecular characterization of cancer mechanisms

Publications

. Synthetic lethality guiding selection of drug combinations in ovarian cancer.
PLoS One, (14), 1, e0210859, https://doi.org/10.1371/journal.pone.0210859, 2019.

Project Project Project

. Synthetic lethal combinations of low-toxicity drugs for breast cancer identified in silico by genetic screens in yeast.
Oncotarget, (9), 91, 36379-91, https://doi.org/10.18632/oncotarget.26372, 2018.

Project Project

. Mass spectrometric-bioinformatic identification of a protein subset that characterizes the cellular activity of anticancer peptides.
Journal of Proteome Research, (13), 11, 5250–5261, https://doi.org/10.1021/pr500510v, 2014.

Project

. Recurrence-free survival in prostate cancer is related to increased stromal TRAIL expression.
Cancer, (117), 6, 1172–1182, https://doi.org/10.1002/cncr.25504, 2011.

Project

. Natural Immunity Enhances the Activity of a DR5 Agonistic Antibody and Carboplatin in the Treatment of Ovarian Cancer.
Molecular Cancer Therapeutics, (9), 4, 1007–1018, https://doi.org/10.1158/1535-7163.MCT-09-0933, 2010.

Project

. The role of c-FLIPL in ovarian cancer: Chaperoning tumor cells from immunosurveillance and increasing their invasive potential.
Gynecologic Oncology, (117), 3, 451–459, https://doi.org/10.1016/j.ygyno.2010.02.024, 2010.

Project